Priority Date: 20.03.12 (FR 20120052497)

HB-EGF INHIBITOR DERIVED FROM THE R DOMAIN OF DIPHTHERIA TOXIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF THE HB-EGF/EGFR PATHWAY

  • Application ID: EP13720081
  • Status: EXAMINATION IN PROGRESS

Attorneys

operating since 1972
1095.65
Headquarter in Paris and 3 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading
operating since 1906
Headquarter in Paris and 7 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
Employment test 51 - 200 employees
Company dna gevers
operating since 1898
1234.07
Headquarter in Antwerp and 8 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61, C07, C12, and G01. Cabinet Orès is specialized in the combination A61, C07, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 52 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 20.03.2012 - Priority Date (FR 20120052497)
  • 26.09.2013 - Publication A1 (WO2013140335)
  • 28.01.2015 - Publication A1 (EP2828285)